| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,588,000 | 3,494,000 | 3,907,000 | 4,910,000 | | Cost of Revenue | 3,066,000 | 2,971,000 | 3,239,000 | 3,686,000 | | | Gross Profit | 522,000 | 523,000 | 668,000 | 1,224,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 49,000 | 48,000 | 52,000 | 61,000 | | Non Recurring | (1,000) | (1,000) |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 474,000 | 476,000 | 616,000 | 1,163,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | (11,000) | (3,000) | (22,000) | | Earnings Before Interest And Taxes | 473,000 | 465,000 | 613,000 | 1,141,000 | | Interest Expense | 80,000 | 82,000 | 53,000 | 48,000 | | Income Before Tax | 393,000 | 383,000 | 560,000 | 1,093,000 | | Income Tax Expense | 124,000 | 117,000 | 179,000 | 342,000 | | Minority Interest |
-
| 2,000 | (2,000) | 25,000 | | | | Net Income From Continuing Ops | 269,000 | 268,000 | 379,000 | 776,000 | | | Non-recurring Events | | Discontinued Operations | (3,000) | (1,000) | (1,000) | (308,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 266,000 | 267,000 | 378,000 | 468,000 | | Preferred Stock And Other Adjustments | (4,000) | (5,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $262,000 | $262,000 | $378,000 | $468,000 |
|
0.02% Nasdaq 0.00%
Income Statement
